Quarterly report pursuant to Section 13 or 15(d)

Business, Presentation and Recent Accounting Pronouncements (Details)

v3.23.1
Business, Presentation and Recent Accounting Pronouncements (Details)
3 Months Ended
Feb. 03, 2023
USD ($)
Sep. 27, 2022
shares
Mar. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Sep. 26, 2022
shares
Sep. 23, 2022
shares
Subsidiary, Sale of Stock [Line Items]            
Reverse stock split ratio   0.025        
Common stock, shares authorized (in shares) | shares     50,000,000 50,000,000   50,000,000
Number of fractional shares issued | shares   0        
Common stock outstanding (in shares) | shares   1,079,045 1,919,270 1,796,472 43,163,123  
Cash and cash equivalents     $ 3,426,067 $ 5,964,556    
Accumulated deficit     (136,331,495) $ (134,462,959)    
Incurred expenses to related party vendor     $ 100,000      
Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Equity line of credit (up to) $ 10,000,000          
Private Placement            
Subsidiary, Sale of Stock [Line Items]            
Net proceeds $ 100,000